Mira Pharmaceuticals, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
MIRA on Nasdaq
Location
1200 Brickell Avenue, Suite 1950 #1183, Miami, FL

Insiders trading volume in the past year

Mira Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Brian McNulty 10%+ Owner $5M Aug 28, 2024
Erez Aminov Chief Executive Officer, Director $4.84M -$134K -2.69% Oct 1, 2025
George Cappy 10%+ Owner $4.47M Aug 7, 2023
Adam Kaplin Pres. & Chief Scientific Off. $311K Aug 2, 2023
Christopher Chapman Executive Chairman, Director $311K Aug 17, 2023
Bradley Kroenig Director $77.7K Aug 2, 2023
Hugh McColl III Director $62.2K Aug 2, 2023
David C. Vorhoff Director $62.2K Aug 2, 2023
Talhia Tuck Director $31.1K Aug 2, 2023
Denil Shekhat Director $30.2K Oct 1, 2025
Alan Weichselbaum Chief Financial Officer May 15, 2025
Matthew Pratt Whalen Director Dec 9, 2024
Edward MacPherson Director Dec 9, 2024
Michelle Yanez Chief Financial Officer Dec 9, 2024
Christos Nicholoudis Director Aug 17, 2023
Matthew Paul Del Giudice Director Dec 9, 2024
Bay Shore Trust 10%+ Owner Nov 15, 2023
Brian Daly Director Oct 25, 2023
Michael Allen Jerman Director Mar 25, 2024

Recent Insider Transactions by Companies or Individuals for Mira Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.